Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Metabolic Engineering . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116286761A reveals novel aldolase screening for 4-hydroxy-2-ketobutyric acid synthesis. Enables cost-effective, scalable biomanufacturing of key pharmaceutical intermediates.
Patent CN103509726A details microbial synthesis of beta-amyrin. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN115851559A reveals a novel recombinant E. coli route for 3,4-DHBA. Discover cost-effective biosynthesis solutions and supply chain advantages for chiral intermediates.
Patent CN114672525A reveals a novel biosynthetic route for N-acetyl-5-methoxytryptamine using engineered E. coli, offering a sustainable alternative to chemical synthesis for pharmaceutical applications.
Patent CN111484962B enables efficient 5α-AD production via engineered Mycobacterium. Discover cost reduction in steroid manufacturing and reliable supply chain solutions.
Novel E. coli pathway boosts ergothioneine yield. Cost-effective fermentation for nutritional ingredients. Supply chain reliability ensured.
Patent CN114150009A reveals a novel enzymatic route for ephedrine using engineered E. coli and yeast, offering high yield and environmental compliance for pharma supply chains.
Patent CN106191089B accelerates 5-AVA yield via transporter overexpression, offering cost-effective supply chain solutions for global pharmaceutical and chemical manufacturers.
Patent CN101984066A reveals a high-yield biological method for L-phenylalanine production, reducing acetate inhibition and offering significant cost advantages for reliable amino acid suppliers.